Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsA recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.
The newly approved inhibitor is for patients who previously received another drug of the same class.
1.
Adding cell-based vaccine to liver cancer therapy can slow cancer progression
2.
Climate change is expected to increase the number of suicide deaths
3.
Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.
4.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
2.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
3.
New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation
4.
Cancer Cachexia: Emerging Therapeutic Strategies
5.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge